A multicenter prospective study was conducted in Israel, in order to i
dentify indicators of good prognosis of opiate dependent patients who
would benefit from naltrexone (NTX) treatment. 72 israeli housing proj
ect subjects who applied for treatment to government drug rehabilitati
on centres were included in the study. After undergoing detoxification
in outpatient settings, the subjects were randomly divided in two gro
ups, each receiving two different dosages of NTX 25 mg and 50 mg, on a
daily basis during six months. After the NTX treatment the sample was
followed up for a 5 year period. The basic criterion for the assessme
nt of clinical outcome was the retention rate. This parameter reached
61.1% at six months, a result superior to any other previously reporte
d with a group of suburban opiate dependents. Successful outcome corre
lated with predictors defined by stable relationships, steady job, goo
d social functioning as measured by completion of compulsory military
service and a later onset of drug abuse. In the NTX free follow-up per
iod of 5 years, the results remained similar. The authors presume that
the specific characteristics of Israeli society and extraneous factor
s may also account for the good clinical results.